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A solid-phase synthesis of tetrahydroquinoline-derived polycyclic 4, having a medium size ring with an
enamide functionality, was achieved from tetrahydroquinoline derivative 3 in five steps with overall 40-
45% yield. An enantiopure, tetrahydroquinoline-derived â-amino ester, 1, was converted into compound 2
that has a free phenolic hydroxyl group as an anchoring site for solid-phase synthesis. The solid-phase
worked well for this sequence, in which the synthesis of the unsaturated eight-membered enamide lactam
was obtained by a ring-closing metathesis approach. Compound 4 is a novel, natural product-like polycyclic
derivative that could further be utilized in library generation for developing small molecule chemical probes.
Introduction
Due to the growing interest in having small molecules that
could help in understanding protein-protein interactions-
based signal transduction, the demand for the generation of
small molecule libraries that are inspired by bioactive natural
products has grown significantly.1 Many of these pathways
are highly complex and present tremendous challenges with
the use of classical tools.2 Rapid access to natural product-
like small molecules having structural complexity and
diversity is crucial for systematically dissecting the functions
of complex protein networking and for understanding cell-
signaling pathways.3 There are several examples in the
literature in which complex natural products are shown to
be specific modulators of protein functions and protein-
protein interactions.4 The complex nature, the three-
dimensional architecture, and the number of protein-binding
functional groups presented in three-dimensional arrays are
some of the unique features that are embedded in natural
products.5 Some of these features make them highly attractive
small molecule chemical probes for understanding protein
functions.
Synthesis Plan
With the goal of obtaining rapid access to natural product-
like tetrahydroquinoline-based complex polycyclic deriva-
tives, we developed a practical, enantioselective solution
synthesis of tetrahydroquinoline chiral scaffold 1 (Scheme
1). This scaffold was further utilized to obtain complex
polycyclics leading to library generation by partial solid-
phase synthesis.6 Due to the wide range of bioactive natural
products having a tetrahydroquinoline moiety7 and the
presence of medium to large size rings,8 this type of scaffold
was selected for our studies and to map the three-dimensional
space around this scaffold toward the synthesis of function-
alized medium size rings. The library generation of polycy-
clics having functionalized medium to large ring derivatives
is still in its infancy and presents tremendous challenges from
the design strategies.9
Herein, we outline our solid-phase library approach to the
synthesis of tetrahydroquinoline-based polycyclics having a
functionalized eight-membered ring including the enamide
functional group (3). This derivative can then be subjected
to a ring-conformation-controlled, stereoselective Michael-
type reaction followed by hydroxyl group derivatization
giving three sites for introducing diversity as shown in 4.
The plan is to utilize the enantiopure â-amino acid derivative,
1, and then modify the side chain to incorporate the allylic
hydroxyl group to obtain compound 2. The synthesis of an
eight-membered ring having an enamide functional group
can be obtained by a ring-closing metathesis (RCM) as the
key reaction in our approach. To our knowledge, there are
no examples in the literature that utilize the scope of the
RCM (solution and solid-phase synthesis) to obtain an eight-
membered ring having an enamide functional group.10
Results and Discussion
To test the feasibility of this strategy, our model solution-
phase studies are shown in Scheme 2. An enantiopure,
tetrahydroquinoline-based â-amino acid derivative, 6, was
utilized in our study.6 The N-alloc protected â-amino
aldehyde was prepared and then subjected to a Lewis-acid-
mediated Grignard reaction giving the corresponding hy-
droxyl derivatives, 8a and 8b. Both isomers 8a and 8b were
obtained in near equal yields and then utilized further to
explore the scope of the ring-closing metathesis reaction. For
example, compound 8a was subjected to N-alloc removal
and acryloylation (9) and was then subjected to RCM. To* Author to whom correspondence should be addressed. Phone: (613)993-7014. Fax: (613) 952-0068. E-mail: Prabhat.Arya@nrc.ca.
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our pleasant surprise, this reaction was very clean, thus giving
the desired eight-membered ring derivative, 10, having an
enamide functional group in 83% yield. The product was
well characterized by 2D NMR studies. To our knowledge,
the use of this approach to obtain medium size rings having
an enamide functional group has not been utilized before.
The novelty of this approach lies in the formation of a
functionalized ring skeleton that can further be utilized in
asymmetric diversity-oriented reactions. Under similar condi-
tions, the other allylic alcohol derivative 8b gave the expected
cyclic enamide product in very high yield (88%). In both
cases, the stereochemistry of the -OAc group in the eight-
membered ring was assigned by NOE studies (see Figure 1
for the NOESY spectrum). Further, model studies with a
hetero Michael reaction were carried out on eight-membered
rings having enamide functional groups. Compounds 10 and
14 were independently subjected to thiol addition. To our
surprise, in both cases the major product was influenced by
the ring conformation, and the nucleophilic attack was
independent from the stereochemistry of the -OAc group
in the eight-membered ring. In both cases, the two isomers
were found to be in a ratio of 7-8:1 and the major isomer
resulted from an attack from the â-face. One could explain
this reaction as the ring conformation control, and it has very
little influence from the chiral group present on the midsize
ring system. This conformation-controlled hetero Michael
reaction opens an attractive approach for introducing an
asymmetric diversity site in a solid-phase synthesis. To
Scheme 1. Natural Product-Like, Tetrahydroquinoline-Derived Polycyclics Having a Functionalized Eight-Membered Ring
Scheme 2
(a) (i) LiBH4, 95%; (ii) allyl chloroformate, pyridine, 89%; (iii) DMSO, SO3-pyridine complex, Et3N, 95%. (b) ZnCl2, allylMgBr, 89%. (c) (i) Ac2O,
DMAP, 83-88%; (ii) Pd(PPh3)4, morpholine, room temp, 98%; (ii) acryloyl chloride, pyridine, 0 °C, 55-60%. (d) 20 mol % second-generation Grubbs’
catalyst, dichloromethane, reflux, 1 h, 83% (10) and 88% (14). (e) (i) PhCH2CH2SH, BuLi, 76-84%; (ii) p-TSA; (iii) BzCl, pyridine, 83-88% for two
steps.
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complete the sequence, in both cases the hetero Michael
products were then subjected to acetonide removal and
acylation giving the expected compounds (11 and 12 from
10; 15 and 16 from 14). Following the success with the
solution synthesis, manual solid-phase synthesis was then
undertaken, and it is shown in Scheme 3. Compound 18 was
prepared from 6 in a number of steps as described before
and then subjected to a Grignard reaction giving two
diastereomers, 19 and 20. Both these products were separated
and fully characterized. Following this, compound 19 was
immobilized onto the solid support using a bromoWang resin
(loading ∼91%, determined after cleavage from the support
with 5% TFA). To continue further, this compound 21 was
then subjected to N-alloc removal, followed by acryloylation
giving product 22. It was then subjected to ring-closing
metathesis that successfully gave the cyclic product on the
Figure 1. NOESY of compounds 10 and 14.
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solid phase. Thus, compound 24 (see Figure 2 for the
NOESY spectrum) was obtained after cleavage from the
support (5% TFA) with an overall 40-45% yield for the
five steps from 21. Further work is in progress to complete
the sequence on the solid phase that involves (i) thiol
addition, (ii) acteonide removal (PPTS), (iii) acylation of the
hydroxyl groups, and (iv) cleavage from the support (5%TFA).
The solid-phase synthesis method developed in our system
can easily be utilized in library generation by exploring three
diversity sites, and this will be reported in due course.
Summary
A solid-phase synthesis of a tetrahydroquinoline-derived
polycyclic compound having a medium size ring with an
enamide functional group has been achieved that can further
be utilized in library generation. A key step in our approach
was the ring-closing metathesis reaction to obtain an eight-
membered ring having an enamide functionality. This
approach worked very nicely on the solid phase, and the final
product obtained was well characterized by extensive NMR
studies. With the use of the solid-phase synthesis method
discussed herein, further work is ongoing for library genera-
tion by an IRORI split and mix type approach, and it will
be reported in due time.
Experimental Section
General Methods. The materials were obtained from
commercial suppliers and used without purification. THF and
CH2Cl2 were distilled under N2 over sodium/benzophenone
and CaH2, respectively. All NMR experiments were recorded
on a Bruker DRX-400. Unless otherwise noted, proton and
carbon chemical shifts are reported in ppm using residual
CHCl3 as an internal standard at 7.26 and 77.0 ppm,
respectively. Analysis by mass spectrometry was performed
on a VG Quattro I (Micromass) mass spectrometer equipped
with a pneumatically assisted electrospray ionization source,
operating in positive mode. The enantiomeric excess was
determined by chiral HPLC, using a Hewlett-Packard (Agi-
lent) 1090 LC equipped with a diode array detector and a
CHIRACEL-OD column.
Solution-Phase Synthesis. Compound 6a. To a solution
of the carboxyl ester 6 (1.10 g, 2.77 mmol) in THF (25 mL)
was added lithium borohydride (2.0 M in THF, 2.77 mL,
5.54 mmol) slowly at 0 °C. The reaction mixture was stirred
at room temperature overnight. The reaction was quenched
with saturated NH4Cl, extracted with dichloromethane (3 ×
10 mL), dried over Na2SO4, filtered, and concentrated.
Purification by flash chromatography on silica gel (3:1,
hexane/ethyl acetate) afforded the product 6a (934 mg, 95%)
as a yellow oil. Rf: 0.20 (2:1, hexane/ethyl acetate). 1H
NMR: (400 MHz, CDCl3) δ ) 7.43-7.26 (m, 5H), 6.89
(d, J ) 2.05 Hz, 1H), 6.71 (dd, J ) 2.74 Hz, 8.60 Hz, 1H),
6.43 (d, J ) 8.66 Hz, 1H), 4.99 (d, J ) 4.3 Hz, 2H), 4.71
(d, J ) 8.89 Hz, 2H), 3.89-3.83 (m, 2H), 3.71 (m, 1H),
3.63 (t, J ) 9.35 Hz, 1H), 1.94-1.86 (m, 1H), 1.57 (m, 1H),
1.55 (s, 3H), 1.51 (s, 3H) ppm. 13C NMR: (100 MHz,
Scheme 3
(a) (i) LiBH4, 95%; (ii) H2, 10% Pd/C, 88%; (iii) allyl chloroformate, pyridine, 70%; (b) DMSO, SO3-pyridine complex, Et3N, 84%. (c) ZnCl2, allylMgBr,
72%. (d) BromoWang resin, NaI, Cs2CO3. (e) (i) Ac2O, DMAP; (ii) Pd(PPh3)4, N-methylmorpholine, AcOH; (iii) acryloyl chloride, pyridine. (f) Second-
generation Grubbs’ catalyst, dichloromethane, reflux. (g) 5% TFA (40-45% for five steps).
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CDCl3) δ ) 151.40, 137.93, 136.79, 128.92, 128.16, 127.90,
121.23, 116.07, 114.17, 113.83, 110.69, 80.30, 77.87, 73.07,
61.12, 56.06, 38.36, 27.53, 27.43 ppm. LRMS: MS (ES+)
m/z ) 356.3 (M + 1).
Compound 6b. To a solution of 6a (480 mg, 1.35 mmol)
in dichloromethane (20 mL), at 0 °C, under N2, was added
pyridine (120 µL, 1.48 mmol) and allyl chloroformate (144
µL, 1.35 mmol). After keeping the reaction mixture for 2 h
at 0 °C under N2, it was quenched with a saturated solution
of ammonium chloride. The aqueous layer was washed 3
times with dichloromethane, and then the combined organic
layer was dried over MgSO4, filtered, and concentrated under
vacuum. The residue was purified by flash chromatography
on silica gel (1:1, hexane/ethyl acetate) giving compound
6b (530 mg, 89%) as a colorless oil. Rf: 0.56 (1:1, hexane/
ethyl acetate). LRMS: MS (ES+) m/z ) 440.2 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.45-7.33 (m, 5H), 7.26
(m, 1H), 6.98 (d, J ) 2.43 Hz, 1H), 6.87 (dd, J ) 2.72, 8.71
Hz, 1H), 5.90 (m, 1H), 5.28-5.20 (m, 2H), 5.07 (dd, J )
7.32, 11.50 Hz, 2H), 4.69 (dd, J ) 5.27, 13.42 Hz, 1H),
4.60 (m, 1H), 4.51 (d, J ) 9.34 Hz, 1H), 4.45 (m, 1H), 3.74
(m, 2H), 3.31 (t, J ) 8.82 Hz, 1H), 2.04 (m, 2H), 1.58 (s,
3H), 1.49 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ )
137.10, 132.55, 128.99, 128.47, 128.12, 127.97, 118.36,
114.59, 113.87, 107.78, 101.03, 76.61, 70.73, 67.29, 59.46,
39.94, 38.64, 27.49, 27.43 ppm.
Compound 7. To a solution of 6b (500 mg, 1.136 mmol)
in dichloromethane (15 mL) at 0 °C, under N2, was added
triethylamine (475 mL, 3 equiv), DMSO (3.39 mL, 47.73
mmol), and sulfur trioxide-pyridine complex (543 mg, 3.41
mmol). After 1 h at 0 °C, the reaction was quenched with a
solution of saturated ammonium chloride. The organic layer
was extracted and dried with magnesium sulfate. After
filtration and evaporation of the solvent, the crude product
was purified by column chromatography on silica gel (3:1
hexane/ethyl acetate) to afford compound 7 as a colorless
oil (473 mg, 95%). Rf: 0.82 (1:1, hexane/ethyl acetate), 0.47
(2:1, hexane/ethyl acetate). LRMS: MS (ES+) m/z ) 438.3
(M + 1). 1H NMR: (400 MHz, CDCl3) δ ) 9.83 (s, 1H),
7.47-7.34 (m, 6H), 7.00 (d, J ) 2.29 Hz, 1H), 6.90 (dd, J
) 2.82, 8.82 Hz, 1H), 5.94 (m, 1H), 5.30 (d, J ) 17.31 Hz,
1H), 5.25 (d, J ) 10.52 Hz, 1H), 5.12 (d, J ) 11.50 Hz,
1H), 5.07 (d, J ) 11.50 Hz, 1H), 4.70 (m, 2H), 4.63 (m,
1H), 4.55 (d, J ) 9.23 Hz, 1H), 3.38 (t, J ) 9.15 Hz, 1H),
2.87 (ddd, J ) 1.90, 5.38, 15.53 Hz, 1H), 2.77 (ddd, J )
3.62, 5.94, 15.48 Hz, 1H), 1.61 (s, 3H), 1.50 (s, 3H) ppm.
13C NMR: (100 MHz, CDCl3) δ ) 199.23, 157.30, 137.09,
132.54, 132.38, 129.00, 128.47, 127.96, 127.72, 127.10,
Figure 2. NOESY of compound 24 prepared by solid-phase synthesis.
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114.83, 113.99, 107.94, 83.21, 76.55, 70.72, 67.44, 53.84,
48.82, 27.48, 27.43 ppm.
Compounds 8a and 8b. To a solution of zinc chloride
(4.12 mL of a 1.0 M solution in ether, 4.12 mmol) in
anhydrous ether (15 mL) was added a solution of aldehyde
7 (450 mg, 1.03 mmol), in anhydrous ether (8 mL) at -78
°C. After 30 min of stirring at -78 °C, allylmagnesium
bromide (6.18 mL of a 1.0 M solution in ether, 6.18 mmol)
was added, and the mixture was stirred at -78 °C for 2 h.
The reaction mixture was then allowed to warm at room
temperature and was further stirred for 1 h. The reaction was
quenched at 0 °C with a solution of saturated ammonium
chloride. The organic layer was collected and washed with
a saturated solution of ammonium chloride. It was dried over
sodium sulfate and then evaporated. Purification of the crude
product by column chromatography on silica gel (1:3, ethyl
acetate/hexane) gave a mixture two diastereomers, 8a and
8b (8a ) 243 mg and 8b ) 200 mg). The overall yield of
the reaction was 89%.
8a: Rf: 0.50 (3:1, hexane/ethyl acetate). LRMS: MS (ES+)
m/z ) 480.4 (M + 1). 1H NMR: (400 MHz, CDCl3) δ )
7.47-7.36 (m, 5H), 7.27 (s, 1H), 7.00 (d, J ) 2.58 Hz, 1H),
6.89 (dd, J ) 2.58, 8.74 Hz, 1H), 5.91 (m, 2H), 5.24 (m,
2H), 5.11 (m, 4H), 4.71 (dd, J ) 5.28, 13.40 Hz, 1H), 4.60
(m, 1H), 4.53 (d, J ) 9.12 Hz, 1H), 4.46 (m, 1H), 3.86 (m,
1H), 3.31 (t, J ) 9.04 Hz, 1H), 2.30 (m, 2H), 1.72 (m, 2H),
1.59 (s, 3H), 1.51 (s, 3H) ppm. 13C NMR: (100 MHz,
CDCl3) δ ) 171.56, 157.54, 137.08, 135.60, 133.32, 132.49,
129.00, 128.47, 128.24, 127.96, 126.99, 118.33, 117.41,
114.63, 113.86, 107.77, 84.85, 77.63, 70.73, 67.36, 60.80,
43.57, 41.79, 31.33, 27.46, 27.40, 21.45, 14.60 ppm.
8b: Rf: 0.28 (3:1, hexane/ethyl acetate). LRMS: MS (ES+)
m/z ) 480.4 (M + 1). 1H NMR: (400 MHz, CDCl3) δ )
7.47-7.31 (m, 6H), 7.00 (d, J ) 2.69 Hz, 1H), 6.89 (dd, J
) 2.69, 8.74 Hz, 1H), 5.93 (m, 1H), 5.86 (m, 1H), 5.32 (m,
1H), 5.24 (d, J ) 10.27 Hz, 1H), 5.10 (m, 4H), 4.72 (dd, J
) 5.18, 13.10 Hz, 1H), 4.65 (m, 1H), 4.54 (d, J ) 9.02 Hz,
1H), 4.50 (m, 1H), 3.90 (m, 1H), 3.38 (t, J ) 8.98 Hz, 1H),
2.30 (t, J ) 6.61 Hz, 2H), 2.19 (m, 1H), 1.66 (m, 1H), 1.60
(s, 3H), 1.52 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ
) 171.50, 157.00, 136.97, 134.96, 132.73, 132.49, 128.79,
128.24, 127.75, 127.62, 127.23, 118.14, 117.85, 114.40,
113.65, 107.58, 84.07, 76.44, 70.53, 66.95, 60.61, 42.22,
41.96, 31.13, 27.31, 21.26, 14.41 ppm.
Compound 8a-1. To a solution of 8a (243 mg, 0.507
mmol) in dichloromethane (5 mL) was added acetic anhy-
dride (96 µL, 1.014 mmol) and DMAP (71 mg, 0.58 mmol).
The reaction mixture was stirred for 3 h at room temperature
and then quenched with aqueous ammonium chloride. After
an extraction with dichloromethane, the organic layer was
dried over sodium sulfate and then evaporated to dryness.
The crude product obtained after evaporation of the solvent
was purified by column chromatography on silica gel (3:1
hexane/ethyl acetate) giving compound 8a-1 as a colorless
oil (83% yield, 220 mg). Rf: 0.53 (3:1, hexane/ethyl acetate).
LRMS: MS (ES+) m/z ) 522.4 (M + 1). 1H NMR: (400
MHz, CDCl3) δ ) 7.47-7.35 (m, 5H), 7.28 (m, 1H), 6.99
(d, J ) 2.10 Hz, 1H), 6.87 (dd, J ) 2.10, 6.10 Hz, 1H),
5.95 (m, 1H), 5.80 (m, 1H), 5.24 (m, 2H), 5.09 (m, 5H),
4.71 (dd, J ) 5.36, 13.32 Hz, 1H), 4.62 (m, 1H), 4.48 (d, J
) 9.06 Hz, 1H), 4.35 (m, 1H), 3.36 (t, J ) 8.98 Hz, 1H),
2.40 (m, 1H), 2.02 (s, 3H), 1.84 (m, 1H), 1.58 (s, 3H), 1.51
(s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ ) 171.12,
170.87, 157.30, 154.93, 137.18, 133.66, 133.09, 132.70,
128.99, 128.80, 128.43, 127.95, 127.62, 118.48, 114.29,
113.83, 107.73, 84.30, 77.62, 76.57, 70.72, 70.69, 67.15,
55.18, 39.15, 38.76, 27.50, 21.80 ppm.
Compound 8a-2. To a solution of 8a-1 (220 mg, 0.42
mmol) in dichloromethane (2 mL) under N2 at room
temperature was added morpholine (74 µL, 0.84 mmol) and
10% of tetrakis(triphenylphosphine) palladium (0) catalyst
(49 mg, 0.042 mmol). The reaction mixture was covered with
tin foil and then stirred for 1 h. The reaction was quenched
with aqueous ammonium chloride and extracted several times
with dichloromethane. The combined organic layer was dried
with magnesium sulfate, filtered, and concentrated under
vacuum. The crude product was purified by column chro-
matography on silica gel (1:3, ethyl acetate/hexane) to give
8a-2 as a yellow oil in 98% yield. Rf: 0.56 (3:1, hexane/
ethyl acetate). LRMS: MS (ES+) m/z ) 438.3 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.45-7.29 (m, 5H), 6.89
(d, J ) 2.50 Hz, 1H), 6.75 (dd, J ) 2.50, 8.69 Hz, 1H),
6.51 (d, J ) 8.69 Hz, 1H), 5.81 (m, 1H), 5.19 (m, 4H), 5.01
(m, 2H), 4.70 (d, J ) 8.24 Hz, 1H), 3.60 (m, 1H), 2.41 (m,
2H), 2.11 (s, 3H), 2.08 (m, 1H), 1.73 (m, 1H), 1.58 (s, 3H),
1.54 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ )
171.61, 151.7, 137.9, 136.8, 133.6, 128.3, 128.1, 127.9,
121.9, 118.7, 116.1, 115.1, 113.5, 110.7, 109.2, 82.4, 80.3,
71.24, 71.00, 69.9, 52.1, 39.6, 39.4, 27.5, 27.5, 21.6 ppm.
Compound 9. To a solution of 8a-2 (180 mg, 0.412 mmol)
in dichloromethane (4.0 mL) was added pyridine (83 µL,
1.030 mmol). The mixture was cooled to 0 °C and then
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acryloyl chloride (67 µL, 0.824 mmol) was added. The
reaction was allowed to stir at room temperature for 2.5 h.
The reaction was quenched with aqueous ammonium chloride
and extracted with dichloromethane, and the organic phases
were dried over magnesium sulfate, filtered, and then
concentrated. The crude product was purified by column
chromatography on silica gel (1:3, ethyl acetate/hexane) to
afford compound 9 as a pale yellow oil (55%, 100 mg). Rf:
0.35 (3:1, hexane/ethyl acetate). LRMS: MS (ES+) m/z )
492.4 (M + 1). 1H NMR: (400 MHz, CDCl3) δ ) 7.48-
7.36 (m, 5H), 7.07 (d, J ) 2.60 Hz, 1H), 6.99 (d, J ) 8.56
Hz, 1H), 6.87 (dd, J ) 2.63, 8.57 Hz, 1H), 6.44 (dd, J )
1.80, 16.81 Hz, 1H), 6.32 (dd, J ) 10.10, 16.79 Hz, 1H),
5.84 (m, 1H), 5.64 (dd, J ) 1.90, 10.08 Hz, 1H), 5.11 (m,
5H), 4.60 (m, 1H), 4.43 (d, J ) 9.01 Hz, 1H), 3.38 (t, J )
8.95 Hz, 1H), 2.51 (m, 1H), 2.41 (m, 1H), 2.26 (m, 1H),
2.02 (s, 3H), 1.71 (m, 1H), 1.57 (s, 3H), 1.51 (s, 3H) ppm.
13C NMR: (100 MHz, CDCl3) δ ) 170.92, 165.63, 158.35,
136.90, 134.52, 133.76, 129.06, 128.90, 128.90, 128.75,
128.57, 127.99, 127.96, 127.30, 118.42, 114.55, 113.68,
108.59, 84.96, 76.60, 70.95, 70.83, 53.92, 38.72, 38.63,
27.48, 21.80 ppm.
Compound 10. To a solution of compound 9 (90 mg,
0.183 mmol) in dichloromethane (9 mL) was added 20 mol
% of second-generation Grubbs’ catalyst (31 mg, 0.0366
mmol). The solution was stirred for 45 min under reflux. It
was then allowed to warm at room temperature and
concentrated under vacuum, and the crude product was
purified by column chromatography on silica gel (ethyl
acetate/hexane 1:3 to 1:1). The eight-membered ring deriva-
tive, 10, was obtained as a white solid (70 mg, 83%). Rf:
0.29 (1:1, hexane/ethyl acetate). LRMS: MS (ES+) m/z )
464.4 (M + 1). 1H NMR: (400 MHz, CDCl3) δ ) 7.47-
7.36 (m, 6H), 7.05 (d, J ) 2.58 Hz, 1H), 6.97 (dd, J ) 2.61,
8.67 Hz, 1H), 6.21 (m, 1H), 6.11 (d, J ) 11.79 Hz, 1H),
5.14 (d, J ) 11.53 Hz, 1H), 5.09 (d, J ) 11.49 Hz, 1H),
4.94 (m, 1H), 4.42 (m, 2H), 3.19 (t, J ) 8.97 Hz, 1H), 2.88
(m, 1H), 2.50 (dd, J ) 7.30, 13.40 Hz, 1H), 2.27 (dd, J )
5.24, 14.33 Hz, 1H), 2.07 (s, 3H), 1.76 (m, 1H), 1.58 (s,
3H), 1.49 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ )
170.44, 168.48, 158.33, 137.08, 134.10, 132.14, 129.56,
129.01, 128.47, 127.95, 127.06, 126.03, 114.53, 113.94,
108.24, 86.35, 76.04, 70.76, 68.61, 55.38, 40.50, 33.99,
30.10, 27.46, 27.37, 21.62 ppm.
Compounds 10a and 10b. To a solution of benzene
ethanethiol (224 µL, 1.6 mmol) in THF (4.0 mL) was added
n-butyllithium (608 µL, 1.52 mmol (2.5 M in hexane) at 78
°C. The reaction mixture was stirred overnight and was
allowed to warm at room temperature. Following this, a
solution of compound 10 (10 mg, 0.0216 mmol) in THF (1.0
mL) was added at 0 °C to 0.5 mL of the lithium salt (9
equiv). After 30 min, the solvent was evaporated, and the
crude product was separated by column chromatography on
silica gel (1:2 ethyl acetate/hexane). The overall yield for
the reaction was 98% giving two diastereomers 10a and 10b
(in a ratio of 8:1).
Compound 10a (R1 ) CH2CH2Ph). Rf: 0.36 (2:1,
hexane/ethyl acetate). LRMS: MS (ES+) m/z ) 602.5 (M
+ 1). 1H NMR: (400 MHz, CDCl3) δ ) 7.45-7.21 (m,
11H), 7.00 (d, J ) 2.66 Hz, 1H), 6.91 (dd, J ) 2.74, 8.78
Hz, 1H), 5.12 (d, J ) 11.52 Hz, 1H), 5.07 (d, J ) 11.51 Hz,
1H), 4.93 (m, 1H), 4.50 (d, J ) 9.04 Hz, 1H), 4.21 (dd, J )
8.24, 11.10 Hz, 1H), 3.45 (m, 1H), 3.32 (dd, J ) 5.48, 13.66
Hz, 1H), 3.22 (t, J ) 8.98 Hz, 1H), 3.02-2.90 (m, 4H),
2.66 (d, J ) 13.64 Hz, 1H), 2.25 (m, 2H), 2.08 (m, 1H),
2.06 (s, 3H), 1.74 (m, 1H), 1.59 (s, 3H), 1.49 (s, 3H) ppm.
13C NMR: (100 MHz, CDCl3) δ ) 170.41, 169.65, 157.74,
140.94, 140.44, 137.13, 133.30, 129.61, 129.02, 128.98,
128.93, 128.90, 128.43, 127.97, 126.81, 126.79, 126.28,
114.61, 113.82, 107.79, 85.18, 76.10, 72.47, 70.72, 56.58,
42.05, 40.62, 36.53, 36.13, 33.44, 27.45, 27.44, 21.58 ppm.
Compound 10b (R1 ) CH2CH2Ph). Rf: 0.61 (2:1,
hexane/ethyl acetate). LRMS: MS (ES+) m/z ) 602.5 (M
+ 1). 1H NMR: (400 MHz, CDCl3) δ ) 7.47-7.22 (m,
11H), 7.02 (d, J ) 2.76 Hz, 1H), 6.93 (dd, J ) 2.81, 8.85
Hz, 1H), 5.35 (m, 1H), 5.13 (d, J ) 11.53 Hz, 1H), 5.08 (d,
J ) 11.53 Hz, 1H), 4.51 (d, J ) 9.25 Hz, 1H), 4.33 (dd, J
) 8.04, 11.10 Hz, 1H), 3.50 (m, 1H), 3.18 (dd, J ) 7.96,
9.15 Hz, 1H), 3.04-2.75 (m, 6H), 2.47 (m, 1H), 2.34 (m,
1H), 2.12 (m, 1H), 2.09 (s, 3H), 1.72 (m, 1H), 1.58 (s, 3H),
1.49 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ) 170.87,
169.84, 157.79, 140.62, 140.44, 137.09, 133.55, 129.02,
128.96, 128.93, 128.90, 128.88, 128.46, 127.94, 126.90,
126.82, 125.96, 114.74, 113.64, 107.95, 85.22, 76.09, 70.73,
69.58, 56.33, 42.62, 41.07, 39.20, 37.86, 36.54, 33.27, 27.47,
27.42, 21.67 ppm.
Compound 8b-1. (83% yield, 220 mg.) Rf: 0.53 (hexane/
ethyl acetate 3:1). LRMS: MS (ES+) m/z ) 522.4 (M + 1).
1H NMR: (400 MHz, CDCl3) δ ) 7.46-7.35 (m, 6H), 6.99
(d, J ) 2.55 Hz, 1H), 6.88 (dd, J ) 2.65, 8.72 Hz, 1H),
5.95 (m, 1H), 5.76 (m,1H), 5.30 (m, 1H), 5.24 (d, J ) 10.12
Hz, 1H), 5.09 (m, 4H), 4.98 (m, 1H), 4.72 (dd, J ) 5.1,
13.3 Hz, 1H), 4.65 (m, 1H), 4.48 (d, J ) 9.12 Hz, 1H), 4.42
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(m, 1H), 3.34 (t, J ) 8.95 Hz, 1H), 2.41 (m, 2H), 2.25 (m,
1H), 1.90 (s, 3H), 1.81 (m, 1H), 1.56 (s, 3 H), 1.49 (s, 3H)
ppm. 13C NMR: (100 MHz, CDCl3) δ ) 170.68, 157.17,
154.98, 137.17, 133.56, 132.99, 132.72, 128.98, 128.43,
127.94, 127.43, 118.53, 118.17, 114.29, 113.79, 107.73,
83.78, 76.61, 77.62, 70.71, 70.69, 67.09, 54.99, 39.28, 37.79,
27.47, 27.36, 21.46 ppm.
Compound 8b-2. (93% yield.) Rf: 0.56 (3:1, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 438.3 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.45-7.32 (m, 5H), 6.89
(d, J ) 2.52 Hz, 1H), 6.73 (dd, J ) 2.58, 8.61 Hz, 1H),
6.45 (d, J ) 8.64 Hz, 1H), 5.80 (m, 1H), 5.16-5.12 (m,
3H), 5.00 (m, 2H), 4.67 (d, 1H, J ) 9.28 Hz), 3.69 (m, 1H),
3.54 (t, J ) 9.34 Hz, 1H), 2.43 (m, 2H), 2.14 (m, 1H), 2.11
(s, 3H), 1.73 (m, 1 H), 1.56 (s, 3H), 1.52 (s, 3H) ppm. 13C
NMR: (100 MHz, CDCl3) δ ) 171.57, 151.43, 136.75,
135.45, 133.41, 128.91, 128.15, 127.91, 121.47, 118.78,
116.52, 116.01, 114.09, 113.72, 110.64, 80.23, 77.61, 72.68,
71.29, 70.99, 54.29, 39.56, 39.34, 27.50, 27.43, 21.45 ppm.
Compound 13. (60% yield.) Rf: 0.36 (3:1, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 492.4 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.48-7.35 (m, 5H), 7.06
(d, J ) 2.58 Hz, 1H), 7.03 (d, J ) 8.58 Hz, 1H), 6.89 (dd,
J ) 2.62, 8.60 Hz, 1H), 6.45 (d, J ) 16.79 Hz, 1H), 6.33
(dd, J ) 10.10, 16.74 Hz, 1H), 5.77 (m, 1H), 5.65 (d, J )
10.08 Hz, 1H), 5.20-5.06 (m, 4H), 4.95 (m, 1H), 4.69 (m,
1H), 4.43 (d, J ) 9.09 Hz, 1H), 3.33 (t, J ) 8.89 Hz, 1H),
2.44 (m, 2H), 2.31 (m, 1H), 1.92 (s, 3H), 1.75 (m, 1H), 1.55
(s, 3H), 1.49 (s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ
) 170.80, 165.87, 158.25, 136.89, 134.47, 133.68, 129.05,
128.95, 128.74, 128.57, 128.19, 127.95, 127.45, 118.45,
114.54, 113.62, 108.60, 84.39, 76.62, 70.90, 70.79, 53.66,
39.16, 37.58, 27.45, 27.32, 21.50 ppm.
Compound 14. (88% yield.) Rf: 0.32 (1:1, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 464.4 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.47-7.34 (m, 6H), 7.04
(d, J ) 2.53 Hz, 1H), 6.96 (dd, J ) 2.69, 8.69 Hz, 1H),
6.09 (m, 2H), 5.29 (m, 1H), 5.12 (d, J ) 11.57 Hz, 1H),
5.08 (d, J ) 11.54 Hz, 1H), 4.63 (m, 1H), 4.46 (d, J ) 9.28
Hz, 1H), 3.20 (t, J ) 9.17 Hz, 1H), 2.82-2.67 (m, 2H),
2.10 (s, 3H), 2.04 (m, 1H), 1.92 (m, 1H), 1.60 (s, 3H), 1.49
(s, 3H) ppm. 13C NMR: (100 MHz, CDCl3) δ ) 170.47,
168.30, 158.24, 137.11, 133.81, 133.28, 129.49, 129.00,
128.44, 127.94, 125.98, 125.91, 114.55, 113.86, 108.26,
86.29, 76.18, 70.73, 68.10, 53.93, 41.34, 33.16, 30.10, 27.50,
27.38, 21.54 ppm.
Compound 14a. LRMS: MS (ES+) m/z ) 602.5 (M +
1). 1H NMR: (400 MHz, CDCl3) δ ) 7.46-7.25 (m, 11H),
7.00 (d, J ) 2.69 Hz, 1H), 6.92 (dd, J ) 2.72, 8.75 Hz,
1H), 5.32 (m, 1H), 5.11 (d, J ) 11.55 Hz, 1H), 5.07 (d, J )
11.58 Hz, 1H), 4.49 (d, J ) 9.21 Hz, 1H), 4.36 (m, 1H),
3.49 (dd, J ) 4.67, 13.54 Hz, 1H), 3.21 (dd, J ) 7.63, 9.18
Hz, 2H), 2.93 (m, 4H), 2.72 (dd, J ) 3.26, 13.65 Hz, 1H),
2.63 (m, 1H), 2.16 (m, 1H), 2.13 (s, 3H), 2.05 (m, 1H), 1.80
(m, 1H), 1.61 (s, 3H), 1.49 (s, 3H) ppm. 13C NMR: (100
MHz, CDCl3) δ ) 170.19, 169.97, 157.81, 140.98, 137.16,
133.24, 129.63, 128.98, 128.96, 128.88, 128.41, 127.95,
126.77, 126.31, 114.53, 113.78, 107.86, 85.63, 76.22, 70.71,
68.84, 54.77, 41.83, 40.22, 38.03, 36.46, 35.77, 33.48, 27.52,
27.41, 21.53 ppm.
Compound 14b. LRMS: MS (ES+) m/z ) 601.2 (M +
1). 1H NMR: (400 MHz, CDCl3) δ ) 7.56 (d, J ) 8.75 Hz,
1H), 7.47-7.25 (m, 10 H), 7.01 (d, J ) 2.79 Hz, 1H), 6.93
(dd, J ) 2.81, 8.75 Hz, 1H), 5.12 (d, J ) 11.60 Hz, 1H),
5.07 (d, J ) 11.60 Hz, 1H), 4.98 (m,1H), 4.51 (d, J ) 9.31
Hz, 1H), 4.46 (m, 1H), 3.43 (m, 1H), 3.24 (dd, J ) 6.98,
9.29 Hz, 1H), 3.14 (t, J ) 12.56 Hz, 1H), 2.95-2.86 (m,
5H), 2.29 (dd, J ) 3.91, 14.72 Hz, 1H), 2.21 (m, 1H), 2.12
(m, 1H), 2.07 (s, 3H), 1.86 (m, 1H), 1.62 (s, 3H), 1.51 (s,
3H) ppm. 13C NMR: (100 MHz, CDCl3) δ) 170.54, 170.53,
157.83, 140.63, 137.12, 133.10, 128.98, 128.97, 128.94,
128.90, 128.43, 127.92, 126.83, 126.04, 114.79, 113.55,
108.07, 85.84, 76.35, 70.70, 70.53, 54.45, 42.63, 42.09,
42.01,40.21, 36.37, 33.86, 27.48, 27.41, 21.78 ppm.
Solid-Phase Synthesis. Compound 6c. To a solution of
6a (1.53 g, 4.31 mmol) in ethanol (40 mL) was added 20 wt
% of palladium on carbon (306 mg). This was stirred under
hydrogen at room temperature for 1 day. The catalyst was
removed by filtration over Celite, and then the solvent was
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evaporated. The residue was purified by flash chromatog-
raphy on silica gel (1:2, hexane/ethyl acetate) to give product
6c as a yellow solid (1 g, 88%). Rf: 0.25 (1:1, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 266.3 (M + 1). 1H
NMR: (400 MHz, DMSO-d6) δ ) 8.43 (s, 1H), 6.42-6.39
(m, 3H), 5.08 (s, 1H), 4.57 (d, J ) 8.93 Hz, 2H), 3.63-3.55
(m, 3H), 3.41 (t, J ) 9.49 Hz, 1H), 1.83-1.78 (m, 1H),
1.63-1.57 (m, 1H), 1.45 (s, 3H), 1.41 (s, 3H) ppm. 13C
NMR: (100 MHz, DMSO-d6) δ ) 148.62, 136.58, 121.15,
115.41, 114.37, 113.04, 110.89, 81.03, 77.81, 58.52, 53.12,
38.25, 27.87 ppm.
Compound 17. To a solution of 6c (900 mg, 3.39 mmol)
in dichloromethane/acetonitrile (35:5 mL) at 0 °C, under N2,
was added pyridine (302 µL, 3.73 mmol) and allyl chloro-
formate (360 µL, 3.39 mmol). After 3 h of reaction at 0 °C,
the reaction was quenched with a saturated solution of
ammonium chloride. The aqueous layer was washed 3 times
with dichloromethane, and then the combined organic layer
was dried over Na2SO4, filtered, and concentrated under
vacuum. The residue was purified by flash chromatography
on silica gel (1:1, hexane/ethyl acetate) to give compound
17 as a white solid (826 mg, 70%). Rf: 0.49 (1:2, hexane/
ethyl acetate), 0.25 (1:1. hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 350.3 (M + 1). 1H NMR: (400 MHz, CDCl3)
δ ) 7.21 (m, 1H), 6.82 (m, 1H), 6.73 (dd, J ) 2.75, 8.63
Hz, 1H), 5.93 (m, 1H), 5.22∼5.30 (m, 2H), 4.71 (dd, J )
5.31, 13.48 Hz, 1H), 4.61 (m, 1H), 4.50 (d, J ) 9.30 Hz,
1H), 4.42 (m, 1H), 3.77 (m,2H), 3.31 (t, J ) 8.69 Hz, 1H),
1.90 (s, 2H), 1.59 (s, 3H), 1.50 (s, 3H) ppm. 13C NMR: (100
MHz, CDCl3) δ ) 154.22, 132.52, 128.28, 118.35, 114.61,
114.02 108.86, 84.64, 77.62, 76.47, 67.31, 59.83, 59.47,
38.58, 27.47, 27.41 ppm.
Compound 18. To a solution of 17 (826 mg, 2.365 mmol)
in dichloromethane (30 mL), under N2 at 0 °C, was added
triethylamine (1.0 mL, 7.095 mmol) and a mixture of DMSO
(7 mL, 99.319 mmol) and sulfur trioxide-pyridine complex
(1.13 g, 7.095 mmol). After 1 h at 0 °C, the reaction was
quenched by a solution of saturated ammonium chloride. The
organic phase was extracted and dried with MgSO4 and then
filtered. After evaporation, the residue obtained was purified
by flash chromatography on silica gel with 2:1 hexane/ethyl
acetate to provide compound 18 as a pale yellow solid (690
mg, 84%). Rf: 0.59 (1:1, hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 348.3 (M + 1). 1H NMR: (400 MHz, CDCl3)
δ ) 9.80 (s, 1H), 7.22 (m, 1H), 6.80 (d, J ) 2.31 Hz, 1H),
6.71 (dd, J ) 2.76, 8.69 Hz, 1H), 5.89 (m, 1H), 5.30-5.21
(m, 2H), 4.71-4.58 (m, 3H), 4.50 (d, J ) 9.27 Hz, 1H),
3.34 (t, J ) 9.15 Hz, 1H), 2.88-2.82 (ddd, J ) 1.73, 7.00,
15.53 Hz, 1H), 2.77-2.71 (ddd, J ) 3.73, 5.73, 9.46 Hz,
1H), 1.57 (s, 3H), 1.47 (s, 3H) ppm. 13C NMR: (100 MHz,
CDCl3) δ ) 199.91, 154.28, 136.85, 132.82, 132.34, 127.87,
126.87, 114.84, 114.26, 108.95, 83.16, 76.43, 67.46, 60.85,
53.81, 48.77, 27.46, 27.41 ppm.
Compound 19. (36% yield.) Rf: 0.36 (3:2, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 390.4 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.19 (m, 1H), 6.83 (d, J )
2.52 Hz, 1H), 6.74 (dd, J ) 2.56, 8.6 Hz, 1H), 5.89 (m,
2H), 5.28 (m, 3H), 5.10 (m, 2H), 4.70 (dd, J ) 5.20, 13.53
Hz, 1H), 4.61 (m, 1H), 4.50 (d, J ) 9.04 Hz, 1H), 4.43 (m,
1H), 3.87 (m, 1H), 3.30 (t, J ) 8.97 Hz, 1H), 2.28 (m, 2H),
1.76 (m, 2H), 1.58 (s, 3H), 1.49 (s, 3H) ppm. 13C NMR:
(100 MHz, CDCl3) δ ) 171.71, 154.44, 135.53, 133.68,
132.46, 128.39, 126.79, 118.33, 117.48, 114.64, 114.02,
108.86, 84.81, 77.61, 76.43, 67.37, 55.35, 43.49, 41.75,
27.44, 27.38 ppm.
Compound 20. (36% yield.) Rf: 0.26 (3:2, hexane/ethyl
acetate). LRMS: MS (ES+) m/z ) 390.4 (M + 1). 1H
NMR: (400 MHz, CDCl3) δ ) 7.28 (m, 1H), 6.80 (s, 1H),
6.73 (dd, J ) 2.78, 8.61 Hz, 1H), 5.87 (m, 2H), 5.30 (m,
3H), 5.10 (m, 2H), 4.70 (m, 2H), 4.50 (m, 2H), 3.89 (m,
1H), 3.36 (t, J ) 8.95 Hz, 1H), 2.30 (m, 2H), 2.17 (m, 1H),
1.65 (m, 1H), 1.59 (s, 3H), 1.51 (s, 3H) ppm. 13C NMR:
(100 MHz, CDCl3) δ ) 171.51, 154.10, 135.09, 133.19,
132.64, 127.96, 127.17, 118.36, 118.10, 114.60, 114.06,
108.78, 83.16, 77.61, 76.51, 67.18, 55.30, 42.39, 42.11, 27.49
ppm.
Compound 21. BromoWang resin (1.40 mmol/g) was first
washed several times with dichloromethane and DMF and
then suspended for 30 min in DMF. To this resin in DMF
(5 mL) was added a solution of compound 19 (288 mg, 0.74
mmol) in DMF (5.0 mL), sodium iodide (111 mg, 0.74
mmol), and cesium carbonate (241 mg, 0.74 mmol). Both
reagents were dried in the oven overnight prior to use. The
mixture was bubbled vigorously with nitrogen for 40 h. The
resin was successively washed with MeOH (2×), DMF (2×),
water (2×), MeOH (2×), and dichloromethane (3×) and then
dried under vacuum for a few hours. The filtrate containing
the starting material was evaporated, and the residue was
dissolved in DCM. The organic layer was washed with water
and brine, dried over sodium sulfate, filtered, and then
evaporated. The residue was purified by flash chromatog-
raphy on silica gel (1:2, hexane/ethyl acetate). The loading
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was determined to be 85% upon cleavage of the product from
the solid support.
Compound 21a. To the resin 21 (265 mg) in dichloro-
methane (10 mL) was added pyridine (240 µL, 2.96 mmol),
acetic anhydride (140 µL, 1.48 mmol), and 4-(dimethylamino)-
pyridine (14 mg, 0.111 mmol). The mixture was shaken
overnight. The mixture was filtered, and the resin washed
with MeOH (2×), DMF (2×), water (2×), MeOH (2×), and
dichloromethane (3×) and then dried under vacuum for a
few hours.
Compound 21b. To the above resin 21a (265 mg, 0.371
mmol) in dichloromethane (15 mL) was successively added
tetrakis(triphenylphosphine) palladium (214 mg, 0.185 mmol),
N-methylmorpholine (0.4 mL, 3.64 mmol), and acetic acid
(0.8 mL, 13.97 mmol). The mixture was mechanically stirred
overnight. It was washed with MeOH (2×), DMF (2×),
water (2×), MeOH (2×), and dichloromethane (3×) and then
dried under vacuum for a few hours.
Compound 22. To the above resin (265 mg, 0.371 mmol)
in dichloromethane (10 mL) was successively added triethyl-
amine (1.4 mL, 10 mmol) and acryloyl chloride (0.6 mL,
7.4 mmol). The mixture was mechanically stirred overnight.
Then the solution was washed with MeOH (2×), DMF (2×),
water (1×), MeOH (2×), and dichloromethane (4×) and then
dried under vacuum for a few hours.
Compound 23. To the above resin (265 mg, 0.371 mmol)
in dichloromethane (20 mL) was added second-generation
Grubbs catalyst (189 mg, 0.222 mmol) under a nitrogen
atmosphere. The mixture was refluxed for 14 h. It was
washed with MeOH (2×), DMF (2×), water (1×), MeOH
(2×), and dichloromethane (4×) and then dried under
vacuum for a few hours. The 30 mg of resin was submitted
to cleavage with 5% TFA in dichloromethane for 1 h. The
resin was then filtered and washed several times with
dichloromethane. The filtrate was evaporated and dried under
vacuum. The cleaved product was purified over column
chromatography giving the pure cleaved compound (40%
yield for six steps). Rf: 0.18 (ethyl acetate). LRMS: MS
(ES+) m/z ) 334.3 (M + 1). 1H NMR: (400 MHz, acetone-
d6) δ ) 8.36 (s, 1H), 7.41 (d, J ) 8.61 Hz, 1H), 7.06 (d, J
) 2.61 Hz, 1H), 6.77 (dd, J ) 2.65, 8.60 Hz, 1H), 6.15 (m,
1H), 6.00 (d, J ) 11.58 Hz, 1H), 5.64 (s, 1H), 4.86 (m, 1H),
4.77 (s, 1H), 4.34 (d, J ) 7.81 Hz, 1H), 4.27 (dd, J ) 5.50,
10.90 Hz, 1H), 3.24 (m, 1H), 2.83 (m, 1H), 2.43 (dd, J )
7.38, 13.18 Hz, 1H), 2.20 (m, 1H), 1.99 (s, 3H), 1.67 (m,
1H) ppm.
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